{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:13:48Z","timestamp":1792800828307,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Italian National Ministero della Salute","award":["GR-2011-02351422"],"award-info":[{"award-number":["GR-2011-02351422"]}],"id":[{"id":"https:\/\/ror.org\/00789fa95","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Italian National Ministero della Salute","award":["GR-2011-02347036"],"award-info":[{"award-number":["GR-2011-02347036"]}],"id":[{"id":"https:\/\/ror.org\/00789fa95","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Italian National Ministero dellUniversit\u00e0","award":["2010BN3MXM_007"],"award-info":[{"award-number":["2010BN3MXM_007"]}]},{"name":"German Research Foundation DFG","award":["FOR926"],"award-info":[{"award-number":["FOR926"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0682-8","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T05:55:56Z","timestamp":1472795756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Interaction between interleukin-1\u03b2 and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis"],"prefix":"10.1186","volume":"13","author":[{"given":"Antonietta","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fresegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Musella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Sepman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bullitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fantozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maccarrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Mandolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285608100325","volume":"2","author":"IS Haussleiter","year":"2009","unstructured":"Haussleiter IS, Br\u00fcne M, Juckel G. Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord. 2009;2:13\u201329.","journal-title":"Ther Adv Neurol Disord"},{"key":"682_CR2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/1352458510365157","volume":"16","author":"S Lo Fermo","year":"2010","unstructured":"Lo Fermo S, Barone R, Patti F, Laisa P, Cavallaro TL, Nicoletti A, et al. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Mult Scler. 2010;16:742\u20138.","journal-title":"Mult Scler"},{"issue":"2","key":"682_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2004.11.007","volume":"106","author":"J Imitola","year":"2005","unstructured":"Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther. 2005;106(2):163\u201377.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"682_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-5728(91)90073-G","volume":"32","author":"D Maimone","year":"1991","unstructured":"Maimone D, Gregory S, Arnason BG, Reder AT. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol. 1991;32(1):67\u201374.","journal-title":"J Neuroimmunol"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0306-4530(01)00068-3","volume":"27","author":"KG Kahl","year":"2002","unstructured":"Kahl KG, Kruse N, Faller H, Weiss H, Rieckmann P. Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology. 2002;27:671\u201381.","journal-title":"Psychoneuroendocrinology"},{"key":"682_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1750-1326-9-56","volume":"9","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, et al. Interleukin-1\u03b2 causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener. 2014;9:56.","journal-title":"Mol Neurodegener"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-5728(03)00075-4","volume":"137","author":"Y Pollak","year":"2003","unstructured":"Pollak Y, Ovadia H, Orion E, Weidenfeld J, Yirmiya R. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J Neuroimmunol. 2003;137:94\u20139.","journal-title":"J Neuroimmunol"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.expneurol.2012.07.010","volume":"37","author":"N Haji","year":"2012","unstructured":"Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, et al. TNF-\u03b1-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol Elsevier Inc. 2012;37:296\u2013303.","journal-title":"Exp Neurol Elsevier Inc"},{"key":"682_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbi.2013.07.003","volume":"33","author":"S Acharjee","year":"2013","unstructured":"Acharjee S, Nayani N, Tsutsui M, Hill MN, Ousman SS, Pittman QJ. Altered cognitive-emotional behavior in early experimental autoimmune encephalitis\u2014cytokine and hormonal correlates. Brain Behav Immun. 2013;33:164\u201372.","journal-title":"Brain Behav Immun"},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbd.2014.11.022","volume":"74","author":"A Gentile","year":"2015","unstructured":"Gentile A, Fresegna D, Federici M, Musella A, Rizzo FR, Sepman H, et al. Dopaminergic dysfunction is associated with IL-1\u03b2-dependent mood alterations in experimental autoimmune encephalomyelitis. Neurobiol Dis. 2015;74:347\u201358.","journal-title":"Neurobiol Dis"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","volume":"19","author":"I Katona","year":"1999","unstructured":"Katona I, Sperl\u00e1gh B, S\u00edk A, K\u00e4falvi A, Vizi ES, Mackie K, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci. 1999;19:4544\u201358.","journal-title":"J Neurosci"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1523\/JNEUROSCI.0372-06.2006","volume":"26","author":"MR Domenici","year":"2006","unstructured":"Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, et al. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci. 2006;26:5794\u20139.","journal-title":"J Neurosci"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1460-9568.2007.05433.x","volume":"25","author":"D Centonze","year":"2007","unstructured":"Centonze D, Rossi S, De Chiara V, Prosperetti C, Battista N, Bernardi G, et al. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. Eur J Neurosci. 2007;25:1631\u201340.","journal-title":"Eur J Neurosci"},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mcn.2007.03.005","volume":"35","author":"D Centonze","year":"2007","unstructured":"Centonze D, Rossi S, Prosperetti C, Gasperi V, De Chiara V, Bari M, et al. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Mol Cell Neurosci. 2007;35:302\u201310.","journal-title":"Mol Cell Neurosci"},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2008.12.035","volume":"282","author":"G Tao","year":"2009","unstructured":"Tao G, Datta S, He R, Nelson F, Wolinsky JS, Narayana PA. Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry. J Neurol Sci. 2009;282:39\u201346.","journal-title":"J Neurol Sci"},{"key":"682_CR16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","volume":"15","author":"D Baker","year":"2001","unstructured":"Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, et al. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 2001;15:300\u20132.","journal-title":"FASEB J"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.2174\/138161208785740036","volume":"14","author":"D Baker","year":"2008","unstructured":"Baker D, Pryce G. The endocannabinoid system and multiple sclerosis. Curr Pharm Des. 2008;14:2326\u201336.","journal-title":"Curr Pharm Des"},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1750-3639.2011.00477.x","volume":"21","author":"H Zhang","year":"2011","unstructured":"Zhang H, Hilton DA, Hanemann CO, Zajicek J. Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D-evidence for altered expression in multiple sclerosis. Brain Pathol. 2011;21:544\u201357.","journal-title":"Brain Pathol"},{"key":"682_CR19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015;16:705\u201318.","journal-title":"Nat Rev Neurosci"},{"key":"682_CR20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awg224","volume":"126","author":"G Pryce","year":"2003","unstructured":"Pryce G, Ahmed Z, Hankey DJR, Jackson SJ, Croxford JL, Pocock JM, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain. 2003;126:2191\u2013202.","journal-title":"Brain"},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.bbi.2011.03.017","volume":"25","author":"S Rossi","year":"2011","unstructured":"Rossi S, Furlan R, De Chiara V, Muzio L, Musella A, Motta C, et al. Cannabinoid CB1 receptors regulate neuronal TNF-\u03b1 effects in experimental autoimmune encephalomyelitis. Brain Behav Immun. 2011;25:1242\u20138.","journal-title":"Brain Behav Immun"},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1352458509355071","volume":"16","author":"E Ramil","year":"2010","unstructured":"Ramil E, S\u00e1nchez AJ, Gonz\u00e1lez-P\u00e9rez P, Rodr\u00edguez-Antig\u00fcedad A, G\u00f3mez-Lozano N, Ortiz P, et al. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Mult Scler. 2010;16:139\u201346.","journal-title":"Mult Scler"},{"key":"682_CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1352458510388680","volume":"17","author":"S Rossi","year":"2011","unstructured":"Rossi S, Buttari F, Studer V, Motta C, Gravina P, Castelli M, et al. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler. 2011;17:281\u20138.","journal-title":"Mult Scler"},{"key":"682_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/51e012bb-b04f-4100-990d-b59d5de45ba4","volume":"8","author":"S Rossi","year":"2013","unstructured":"Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, et al. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. PLoS One. 2013;8:e82848.","journal-title":"PLoS One"},{"key":"682_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2008.10.047","volume":"66","author":"AR Hariri","year":"2009","unstructured":"Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, et al. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry. 2009;66:9\u201316.","journal-title":"Biol Psychiatry"},{"key":"682_CR26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","volume":"318","author":"S Patel","year":"2006","unstructured":"Patel S, Hillard CJ. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid. J Pharmacol Exp. 2006;318:304\u201311.","journal-title":"J Pharmacol Exp"},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/npp.2008.98","volume":"34","author":"V Micale","year":"2009","unstructured":"Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, et al. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology. 2009;34:593\u2013606.","journal-title":"Neuropsychopharmacology"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2009.369","volume":"301","author":"MN Hill","year":"2009","unstructured":"Hill MN. Impairments in endocannabinoid signaling and depressive illness. JAMA. 2009;301:1165\u20136.","journal-title":"JAMA"},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(10)60935-X","volume":"376","author":"EJ Topol","year":"2010","unstructured":"Topol EJ, Bousser MG, Fox KA, Creager MA, Despres JP, Easton JD, et al. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet. 2010;376:517\u201323.","journal-title":"Lancet"},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1601-183X.2009.00512.x","volume":"8","author":"W Jacob","year":"2009","unstructured":"Jacob W, Yassouridis A, Marsicano G, Monory K, Lutz B, Wotjak CT. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav. 2009;8:685\u201398.","journal-title":"Genes Brain Behav"},{"key":"682_CR31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2010.03.020","volume":"39","author":"CE Beyer","year":"2010","unstructured":"Beyer CE, Dwyer JM, Piesla MJ, Platt BJ, Shen R, Rahman Z, et al. Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol Dis. 2010;39:148\u201355.","journal-title":"Neurobiol Dis"},{"key":"682_CR32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/npp.2009.141","volume":"35","author":"V Chiara De","year":"2010","unstructured":"De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, et al. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology. 2010;35:374\u201387.","journal-title":"Neuropsychopharmacology"},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"13896","DOI":"10.1523\/JNEUROSCI.1515-12.2012","volume":"32","author":"S Rossi","year":"2012","unstructured":"Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, et al. Interleukin-1 causes anxiety by interacting with the endocannabinoid system. J Neurosci. 2012;32:13896\u2013905.","journal-title":"J Neurosci"},{"key":"682_CR34","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1523\/JNEUROSCI.5804-08.2009","volume":"29","author":"D Centonze","year":"2009","unstructured":"Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci. 2009;29:3442\u201352.","journal-title":"J Neurosci"},{"key":"682_CR35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418:530\u20134.","journal-title":"Nature"},{"key":"682_CR36","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1523\/JNEUROSCI.5369-12.2013","volume":"33","author":"G Mandolesi","year":"2013","unstructured":"Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H, et al. Interleukin-1\u03b2 alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. J Neurosci. 2013;33:12105\u201321.","journal-title":"J Neurosci"},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1523\/JNEUROSCI.1682-10.2010","volume":"30","author":"F Napolitano","year":"2010","unstructured":"Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, et al. Role of aberrant striatal dopamine D1 receptor\/cAMP\/protein kinase A\/DARPP32 signaling in the paradoxical calming effect of amphetamine. J Neurosci. 2010;30:11043\u201356.","journal-title":"J Neurosci"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(81)90007-1","volume":"15","author":"JN Crawley","year":"1981","unstructured":"Crawley JN. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav. 1981;15:695\u20139.","journal-title":"Pharmacol Biochem Behav"},{"key":"682_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2013","unstructured":"Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, et al. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS One. 2013;8, e70274.","journal-title":"PLoS One"},{"key":"682_CR40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0163-1047(82)90289-8","volume":"36","author":"K Bulloch","year":"1982","unstructured":"Bulloch K, Hamburger RN, Loy R. Nest-building behavior in two cerebellar mutant mice: staggerer and weaver. Behav Neural Biol. 1982;36:94\u20137.","journal-title":"Behav Neural Biol"},{"key":"682_CR41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mcn.2008.09.001","volume":"40","author":"A Musella","year":"2009","unstructured":"Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, et al. TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci. 2009;40:89\u201397.","journal-title":"Mol Cell Neurosci"},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0149-7634(99)00034-2","volume":"23","author":"A Aubert","year":"1999","unstructured":"Aubert A. Sickness and behaviour in animals: a motivational perspective. Neurosci Biobehav Rev. 1999;23:1029\u201336.","journal-title":"Neurosci Biobehav Rev"},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.taap.2008.05.009","volume":"231","author":"SJ Blossom","year":"2008","unstructured":"Blossom SJ, Doss JC, Hennings LJ, Jernigan S, Melnyk S, James SJ. Developmental exposure to trichloroethylene promotes CD4+ T cell differentiation and hyperactivity in association with oxidative stress and neurobehavioral deficits in MRL+\/+ mice. Toxicol Appl Pharmacol. 2008;231:344\u201353.","journal-title":"Toxicol Appl Pharmacol"},{"key":"682_CR44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-5728(99)00257-X","volume":"104","author":"Y Pollak","year":"2000","unstructured":"Pollak Y, Ovadia H, Goshen I, Gurevich R, Monsa K, Avitsur R, et al. Behavioral aspects of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2000;104:31\u20136.","journal-title":"J Neuroimmunol"},{"key":"682_CR45","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1523\/JNEUROSCI.5346-07.2008","volume":"28","author":"S Rossi","year":"2008","unstructured":"Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, et al. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci. 2008;28:7284\u201392.","journal-title":"J Neurosci"},{"key":"682_CR46","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/brain\/awm160","volume":"130","author":"D Centonze","year":"2007","unstructured":"Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain. 2007;130:2543\u201353.","journal-title":"Brain"},{"key":"682_CR47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12017-013-8249-7","volume":"16","author":"F Mori","year":"2013","unstructured":"Mori F, Nistic\u00f2 R, Mandolesi G, Piccinin S, Mango D, Kusayanagi H, et al. Interleukin-1\u03b2 promotes long-term potentiation in patients with multiple sclerosis. NeuroMolecular Med. 2013;16:38\u201351.","journal-title":"NeuroMolecular Med"},{"issue":"3","key":"682_CR48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12035-009-8061-4","volume":"39","author":"S Rossi","year":"2009","unstructured":"Rossi S, De Chiara V, Musella A, Mataluni G, Sacchetti L, Bernardi G, et al. Adaptations of striatal endocannabinoid system during stress. Mol Neurobiol. 2009;39(3):178\u201384.","journal-title":"Mol Neurobiol"},{"key":"682_CR49","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1523\/JNEUROSCI.1683-10.2010","volume":"30","author":"V Chiara De","year":"2010","unstructured":"De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, et al. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci. 2010;30:8127\u201337.","journal-title":"J Neurosci"},{"key":"682_CR50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/aps.2011.77","volume":"32","author":"JN Picada","year":"2011","unstructured":"Picada JN, Dos Santos Bde J, Celso F, Monteiro JD, Da Rosa KM, Camacho LR, et al. Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol Sin. 2011;32:1225\u201332.","journal-title":"Acta Pharmacol Sin"},{"key":"682_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1254\/jphs.12214FP","volume":"121","author":"D Babovic","year":"2013","unstructured":"Babovic D, Jiang L, Goto S, Gantois I, Sch\u00fctz G, Lawrence AJ, et al. Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine. J Pharmacol Sci. 2013;121:39\u201347.","journal-title":"J Pharmacol Sci"},{"key":"682_CR52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S1461145712000569","volume":"1\u201316","author":"MJ Luque-Rojas","year":"2013","unstructured":"Luque-Rojas MJ, Galeano P, Su\u00e1rez J, Araos P, Sant\u00edn LJ, de Fonseca FR, et al. Hyperactivity induced by the dopamine D2\/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice. Int J Neuropsychopharmacol. 2013;1\u201316:661\u201376.","journal-title":"Int J Neuropsychopharmacol"},{"key":"682_CR53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1471-4159.2008.05336.x","volume":"106","author":"TL Daigle","year":"2008","unstructured":"Daigle TL, Kwok ML, Mackie K. Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J Neurochem. 2008;106:70\u201382.","journal-title":"J Neurochem"},{"key":"682_CR54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.0906e09","volume":"67","author":"SJ Mathew","year":"2006","unstructured":"Mathew SJ, Ho S. Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry. 2006;67:9\u201313.","journal-title":"J Clin Psychiatry"},{"key":"682_CR55","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1038\/npp.2014.121","volume":"39","author":"D R\u00e9vy","year":"2014","unstructured":"R\u00e9vy D, Jaouen F, Salin P, Melon C, Chabbert D, Tafi E, et al. Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions. Neuropsychopharmacology. 2014;39:2662\u201372.","journal-title":"Neuropsychopharmacology"},{"key":"682_CR56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1352458508099477","volume":"15","author":"R Marrie","year":"2009","unstructured":"Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler. 2009;15:385\u201392.","journal-title":"Mult Scler"},{"key":"682_CR57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995;34:301\u20139.","journal-title":"J Affect Disord"},{"key":"682_CR58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/brbi.2000.0597","volume":"15","author":"EP Zorrilla","year":"2001","unstructured":"Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001;15:199\u2013226.","journal-title":"Brain Behav Immun"},{"key":"682_CR59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"682_CR60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2014.09.022","volume":"96","author":"S Rossi","year":"2015","unstructured":"Rossi S, Motta C, Musella A, Centonze D. The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission. Neuropharmacology. 2015;96:105\u201312.","journal-title":"Neuropharmacology"},{"key":"682_CR61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nbd.2011.05.018","volume":"43","author":"G Musumeci","year":"2011","unstructured":"Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, et al. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-\u03b1 and of IL-1\u03b2 in experimental autoimmune encephalomyelitis. Neurobiol Dis. 2011;43:669\u201377.","journal-title":"Neurobiol Dis"},{"key":"682_CR62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2013.06.069","volume":"250","author":"V Chiara De","year":"2013","unstructured":"De Chiara V, Motta C, Rossi S, Studer V, Barbieri F, Lauro D, et al. Interleukin-1\u03b2 alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. Neuroscience. 2013;250:232\u20139.","journal-title":"Neuroscience"},{"key":"682_CR63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fneur.2015.00052","volume":"6","author":"E Dobryakova","year":"2015","unstructured":"Dobryakova E, Genova HM, DeLuca J, Wylie GR. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front Neurol. 2015;6:52.","journal-title":"Front Neurol"},{"key":"682_CR64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2007.09.011","volume":"427","author":"JW Yates","year":"2007","unstructured":"Yates JW, Meij JTA, Sullivan JR, Richtand NM, Yu L. Bimodal effect of amphetamine on motor behaviors in C57BL\/6 mice. Neurosci Lett. 2007;427:66\u201370.","journal-title":"Neurosci Lett"},{"key":"682_CR65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002130100901","volume":"159","author":"C Spielewoy","year":"2002","unstructured":"Spielewoy C, Biala G, Roubert C, Hamon M, Betancur C, Giros B. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berl). 2002;159:2\u20139.","journal-title":"Psychopharmacology (Berl)"},{"key":"682_CR66","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/45251","volume":"402","author":"JA Bibb","year":"1999","unstructured":"Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature. 1999;402:669\u201371.","journal-title":"Nature"},{"key":"682_CR67","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1523\/JNEUROSCI.18-08-02834.1998","volume":"18","author":"DE Garcia","year":"1998","unstructured":"Garcia DE, Brown S, Hille B, Mackie K. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci. 1998;18:2834\u201341.","journal-title":"J Neurosci"},{"key":"682_CR68","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","volume":"32","author":"V Trezza","year":"2012","unstructured":"Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, et al. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J Neurosci. 2012;32:14899\u2013908.","journal-title":"J Neurosci"},{"key":"682_CR69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/mol.114.096495","volume":"87","author":"TH Smith","year":"2015","unstructured":"Smith TH, Blume LC, Straiker A, Cox JO, David BG, McVoy JRS, et al. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation. Mol Pharmacol. 2015;87:747\u201365.","journal-title":"Mol Pharmacol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0682-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:57:21Z","timestamp":1718758641000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0682-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0682-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]},"article-number":"231"}}